ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 944

$418K Total Retail Price of All Prescriptions

Rank: 309 out of 944

445 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 952 904 1 1
AMLODIPINE BESYLATE 478 462 2 5
INDAPAMIDE 456 430 10 3 130
ENALAPRIL MALEATE 386 361 4 43
LEVOTHYROXINE SODIUM 363 337 5 2
LOSARTAN POTASSIUM 354 331 6 16
OMEPRAZOLE 351 268 7 4
WARFARIN SODIUM 339 335 8 7
METOPROLOL TARTRATE 336 305 9 8
FUROSEMIDE 286 286 10 6
ATORVASTATIN CALCIUM 270 243 11 13
ATENOLOL 267 237 12 11
METFORMIN HCL 240 199 13 12
DIOVAN 235 222 14 38
PRAVASTATIN SODIUM 225 182 15 17
LISINOPRIL 207 184 16 3
HYDROCODONE-ACETAMINOPHEN 198 188 S3 17 10
CITALOPRAM HBR 185 163 18 19
ALENDRONATE SODIUM 184 175 19 20
METOPROLOL SUCCINATE 169 164 20 14
HYDROCHLOROTHIAZIDE 154 128 21 9
ALLOPURINOL 130 110 22 22
TAMSULOSIN HCL 115 102 23 27
DONEPEZIL HCL 104 104 24 24
NAMENDA 97 97 25 37
SPIRIVA 91 91 26 65
POTASSIUM CHLORIDE 83 71 27 15
LOVASTATIN 79 58 28 26
CARVEDILOL 79 67 28 30
SERTRALINE HCL 75 75 30 23
CRESTOR 74 63 31 28
DICLOFENAC SODIUM 71 62 32 106
DIGOXIN 69 69 33 39
GABAPENTIN 68 43 34 18
FLUOXETINE HCL 67 48 35 48
ZOLPIDEM TARTRATE 64 63 36 25
POLYETHYLENE GLYCOL 3350 64 56 36 41
PROAIR HFA 56 26 38 56
MIRTAZAPINE 55 55 39 35
SPIRONOLACTONE 52 52 40 44
AMITRIPTYLINE HCL 50 37 R 41 79
PLAVIX 50 49 41 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.